UID,Searchword,API,URL,Title,Summary,Article,Title_Sentiment,Title_Positive,Title_Neutral,Title_Negative,Article_Sentiment,Article_Positive,Article_Neutral,Article_Negative,Verified,Language,Topics,Date,Load_Date,Source
22008,Deutsche Boerse,Twitter API,Twitter,The latest issue of BIOTECH Insight newsletter of Deutsche BÃ¶rse in collaboration with @BiocomDe is out  covering hâ€¦ https://t.co/xFSmrHiEMk,nan,The latest issue of BIOTECH Insight newsletter of Deutsche BÃ¶rse in collaboration with @BiocomDe is out  covering hâ€¦ https://t.co/xFSmrHiEMk,neutral,0.05,0.94,0.01,neutral,0.05,0.94,0.01,True,English,"['BIOTECH Insight newsletter', 'Deutsche BÃ¶rse', 'latest issue', 'collaboration', 'xFSmrHiEMk', 'BIOTECH Insight newsletter', 'Deutsche BÃ¶rse', 'latest issue', 'collaboration', 'xFSmrHiEMk']",2023-04-02,2023-04-10,Unknown
22064,Deutsche Boerse,Twitter API,Twitter,@ftr_investors I would imagine Euronext NV  London Stock Exchange Group and Deutsche Boerse deserve to be amongst tâ€¦ https://t.co/rPB2OYyeZr,nan,@ftr_investors I would imagine Euronext NV  London Stock Exchange Group and Deutsche Boerse deserve to be amongst tâ€¦ https://t.co/rPB2OYyeZr,neutral,0.11,0.87,0.02,neutral,0.11,0.87,0.02,True,English,"['London Stock Exchange Group', 'Euronext NV', 'Deutsche Boerse', 'London Stock Exchange Group', 'Euronext NV', 'Deutsche Boerse']",2023-04-04,2023-04-10,Unknown
22065,Deutsche Boerse,Twitter API,Twitter,Deutsche BÃ¶rse has released its cash market trading volumes for March 2023  witnessing the markets' turnover totaleâ€¦ https://t.co/fv0I1E513o,nan,Deutsche BÃ¶rse has released its cash market trading volumes for March 2023  witnessing the markets' turnover totaleâ€¦ https://t.co/fv0I1E513o,neutral,0.16,0.81,0.03,neutral,0.16,0.81,0.03,True,English,"['cash market trading volumes', 'Deutsche BÃ¶rse', ""markets' turnover totale"", 'March', 'cash market trading volumes', 'Deutsche BÃ¶rse', ""markets' turnover totale"", 'March']",2023-04-04,2023-04-10,Unknown
22066,Deutsche Boerse,Twitter API,Twitter,ETC Group to launch multi-crypto ETP @ETF_Strategy ETC Group is set to launch a new ETP on Deutsche BÃ¶rse Xetra. Tâ€¦ https://t.co/cgOaHouL52,nan,ETC Group to launch multi-crypto ETP @ETF_Strategy ETC Group is set to launch a new ETP on Deutsche BÃ¶rse Xetra. Tâ€¦ https://t.co/cgOaHouL52,neutral,0.09,0.9,0.01,neutral,0.09,0.9,0.01,True,English,"['Deutsche BÃ¶rse Xetra', 'ETC Group', 'multi-crypto ETP', 'new ETP', 'ETF_Strategy', 'Deutsche BÃ¶rse Xetra', 'ETC Group', 'multi-crypto ETP', 'new ETP', 'ETF_Strategy']",2023-04-03,2023-04-10,Unknown
22187,Deutsche Boerse,Twitter API,Twitter,VanEck has launched a new oil sector strategy which is now listed on the London Stock Exchange and Deutsche BÃ¶rse Xâ€¦ https://t.co/u6ONR2CU2V,nan,VanEck has launched a new oil sector strategy which is now listed on the London Stock Exchange and Deutsche BÃ¶rse Xâ€¦ https://t.co/u6ONR2CU2V,neutral,0.17,0.83,0.01,neutral,0.17,0.83,0.01,True,English,"['new oil sector strategy', 'Deutsche BÃ¶rse X', 'London Stock Exchange', 'VanEck', 'new oil sector strategy', 'Deutsche BÃ¶rse X', 'London Stock Exchange', 'VanEck']",2023-04-05,2023-04-10,Unknown
22188,Deutsche Boerse,Twitter API,Twitter,VanEck has launched a new defense sector strategy which is now listed on the London Stock Exchange and Deutsche BÃ¶râ€¦ https://t.co/5FfTSKbn4w,nan,VanEck has launched a new defense sector strategy which is now listed on the London Stock Exchange and Deutsche BÃ¶râ€¦ https://t.co/5FfTSKbn4w,neutral,0.14,0.85,0.01,neutral,0.14,0.85,0.01,True,English,"['new defense sector strategy', 'London Stock Exchange', 'Deutsche BÃ¶r', 'VanEck', 'FfTSKbn4w', 'new defense sector strategy', 'London Stock Exchange', 'Deutsche BÃ¶r', 'VanEck', 'FfTSKbn4w']",2023-04-05,2023-04-10,Unknown
22307,Deutsche Boerse,Twitter API,Twitter,ðŸ“¸#PhotostoryThe Deutsche BÃ¶rse Photography Foundation Prize 2023ðŸ‘‰https://t.co/e1ZKC3pBSzThe shortlisted artistsâ€¦ https://t.co/HwinNtVdV5,nan,ðŸ“¸#PhotostoryThe Deutsche BÃ¶rse Photography Foundation Prize 2023ðŸ‘‰https://t.co/e1ZKC3pBSzThe shortlisted artistsâ€¦ https://t.co/HwinNtVdV5,neutral,0.08,0.91,0.01,neutral,0.08,0.91,0.01,True,English,"['The Deutsche BÃ¶rse Photography Foundation Prize', 'Photostory', 'artists', 'HwinNtVdV5', 'The Deutsche BÃ¶rse Photography Foundation Prize', 'Photostory', 'artists', 'HwinNtVdV5']",2023-04-06,2023-04-10,Unknown
22308,Deutsche Boerse,Twitter API,Twitter,@paddi_hansen Deutsche BÃ¶rse has been on a recruitment drive for crypto talent lately.  ðŸ¤”Curious how this developâ€¦ https://t.co/zfIzMACbwy,nan,@paddi_hansen Deutsche BÃ¶rse has been on a recruitment drive for crypto talent lately.  ðŸ¤”Curious how this developâ€¦ https://t.co/zfIzMACbwy,positive,0.58,0.19,0.23,positive,0.58,0.19,0.23,True,English,"['paddi_hansen Deutsche BÃ¶rse', 'recruitment drive', 'crypto talent', 'paddi_hansen Deutsche BÃ¶rse', 'recruitment drive', 'crypto talent']",2023-04-06,2023-04-10,Unknown
22414,Deutsche Boerse,Twitter API,Twitter,Financial Services Roundup: Market Talk https://t.co/1xAhJCVwzn Deutsche Boerse  Toronto-Dominion Bank and more feaâ€¦ https://t.co/Bz8Jz9qRQn,nan,Financial Services Roundup: Market Talk https://t.co/1xAhJCVwzn Deutsche Boerse  Toronto-Dominion Bank and more feaâ€¦ https://t.co/Bz8Jz9qRQn,neutral,0.06,0.93,0.01,neutral,0.06,0.93,0.01,True,English,"['Financial Services Roundup', 'Market Talk', 'Deutsche Boerse', 'Toronto-Dominion Bank', 'Bz8Jz9qRQn', 'Financial Services Roundup', 'Market Talk', 'Deutsche Boerse', 'Toronto-Dominion Bank', 'Bz8Jz9qRQn']",2023-04-07,2023-04-10,Unknown
22415,Deutsche Boerse,Twitter API,Twitter,Andy Vermaut shares:Financial Services Roundup: Market Talk: Deutsche Boerse  Toronto-Dominion Bank and more featurâ€¦ https://t.co/8MLFc52MMu,nan,Andy Vermaut shares:Financial Services Roundup: Market Talk: Deutsche Boerse  Toronto-Dominion Bank and more featurâ€¦ https://t.co/8MLFc52MMu,neutral,0.08,0.91,0.01,neutral,0.08,0.91,0.01,True,English,"['Andy Vermaut shares', 'Financial Services Roundup', 'Market Talk', 'Deutsche Boerse', 'Toronto-Dominion Bank', 'Andy Vermaut shares', 'Financial Services Roundup', 'Market Talk', 'Deutsche Boerse', 'Toronto-Dominion Bank']",2023-04-07,2023-04-10,Unknown
22544,EuroNext,Bing API,https://uk.finance.yahoo.com/news/innate-pharma-files-2022-universal-050000174.html,Innate Pharma Files Its 2022 Universal Registration Document (Document dâ€™enregistrement universel) and 2022 Annual Report on Form 20-F,"MARSEILLE  France  April 06  2023--(BUSINESS WIRE)--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (""Innate"" or the ""Company"") today announced the filing of its 2022 Universal Registration Document (Document dâ€™enregistrement universel) for the year ...","MARSEILLE  France  April 06  2023--(BUSINESS WIRE)--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (""Innate"" or the ""Company"") today announced the filing of its 2022 Universal Registration Document (Document dâ€™enregistrement universel) for the year ending December 31  2022 with the French market authority ""AutoritÃ© des MarchÃ©s Financiers"" (""AMF"") on April 6  2023. It can be downloaded (in French) on the Companyâ€™s website and on the AMFâ€™s website.The Company also announced today the filing of its annual report on Form 20-F for the year ending December 31  2022 with the United States Securities and Exchange Commission (""SEC""). It can be also be accessed on the Companyâ€™s website and on the SECâ€™s website.About Innate PharmaInnate Pharma S.A. is a global  clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through therapeutic antibodies and its ANKETÂ® (Antibody-based NK cell Engager Therapeutics) proprietary platform.Innateâ€™s portfolio includes lead proprietary program lacutamab  developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas  monalizumab developed with AstraZeneca in non-small cell lung cancer  as well as ANKETÂ® multi-specific NK cell engagers to address multiple tumor types.Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca  as well as leading research institutions  to accelerate innovation  research and development for the benefit of patients.Headquartered in Marseille  France with a US office in Rockville  MD  Innate Pharma is listed on Euronext Paris and Nasdaq in the US.Learn more about Innate Pharma at www.innate-pharma.com and follow us on Twitter and LinkedIn.Information about Innate Pharma sharesISIN codeTicker codeLEI FR0010331421 Euronext: IPH Nasdaq: IPHA 9695002Y8420ZB8HJE29Disclaimer on forward-looking information and risk factorsThis press release contains certain forward-looking statements  including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words  including ""believe "" ""potential "" ""expect"" and ""will"" and similar expressions  is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions  these forward-looking statements are subject to numerous risks and uncertainties  which could cause actual results to differ materially from those anticipated. These risks and uncertainties include  among other things  the uncertainties inherent in research and development  including related to safety  progression of and results from its ongoing and planned clinical trials and preclinical studies  review and approvals by regulatory authorities of its product candidates  the Companyâ€™s commercialization efforts and the Companyâ€™s continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties which could cause the company's actual results  financial condition  performance or achievements to differ from those contained in the forward-looking statements  please refer to the Risk Factors (""Facteurs de Risque"") section of the Universal Registration Document filed with the French Financial Markets Authority (""AMF"")  which is available on the AMF website http://www.amf-france.org or on Innate Pharmaâ€™s website  and public filings and reports filed with the U.S. Securities and Exchange Commission (""SEC"")  including the Companyâ€™s Annual Report on Form 20-F for the year ended December 31  2022  and subsequent filings and reports filed with the AMF or SEC  or otherwise made public  by the Company.Story continuesThis press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.View source version on businesswire.com: https://www.businesswire.com/news/home/20230405005495/en/ContactsInvestorsInnate PharmaHenry WheelerTel.: +33 (0)4 84 90 32 88Henry.wheeler@innate-pharma.frMedia RelationsNewCapArthur RouillÃ©Tel.: +33 (0)1 44 71 00 15innate@newcap.eu",neutral,0.0,1.0,0.0,mixed,0.2,0.2,0.6,True,English,"['2022 Universal Registration Document', 'Innate Pharma', 'enregistrement universel', '2022 Annual Report', 'Form', 'Antibody-based NK cell Engager Therapeutics', 'AutoritÃ© des MarchÃ©s Financiers', 'Private Securities Litigation Reform Act', 'ANKETÂ® multi-specific NK cell engagers', 'cutaneous T cell lymphomas', 'peripheral T cell lymphomas', 'small cell lung cancer', 'lead proprietary program lacutamab', 'global, clinical-stage biotechnology company', 'French Financial Markets Authority', 'Innate Pharma S.A.', 'U.S. Securities', 'United States Securities', 'French market authority', 'multiple tumor types', 'Facteurs de Risque', '2022 Universal Registration Document', 'innate immune system', 'leading research institutions', 'Innate Pharma SA', 'Innate Pharma shares', 'proprietary platform', 'financial condition', 'cancer patients', 'BUSINESS WIRE', 'enregistrement universel', 'annual report', 'Exchange Commission', 'innovative approach', 'therapeutic antibodies', 'trusted partner', 'biopharmaceutical companies', 'ISIN code', 'Ticker code', 'risk factors', 'press release', 'forward-looking statements', 'similar expressions', 'reasonable assumptions', 'other things', 'clinical trials', 'preclinical studies', 'regulatory authorities', 'product candidates', 'commercialization efforts', 'additional discussion', 'public filings', 'subsequent filings', 'source version', 'Media Relations', 'Arthur RouillÃ©', 'Euronext Paris', 'Form 20-F', 'advanced form', 'actual results', 'US office', 'The Company', 'looking information', 'numerous risks', 'Henry Wheeler', 'IPH Nasdaq', 'AMF website', 'MARSEILLE', 'France', 'April', 'IPHA', 'year', 'December', 'immunotherapies', 'portfolio', 'monalizumab', 'AstraZeneca', 'Sanofi', 'innovation', 'development', 'benefit', 'Rockville', 'MD', 'Twitter', 'LinkedIn', 'LEI', 'Disclaimer', 'meaning', 'use', 'words', 'believe', 'expect', 'will', 'uncertainties', 'safety', 'progression', 'ongoing', 'review', 'approvals', 'ability', 'capital', 'performance', 'achievements', 'section', 'reports', 'Story', 'offer', 'solicitation', 'country', 'businesswire', 'Contacts', 'Investors', 'Tel.', 'NewCap', '33', '4', '1']",2023-04-10,2023-04-10,uk.finance.yahoo.com
22545,EuroNext,Twitter API,Twitter,And  On The List Of Winners And Losers Of Monday's Euronext Sessionhttps://t.co/e1lMLKc98D(VIANEWS) - Another dayâ€¦ https://t.co/XeQb1wlthU,nan,And  On The List Of Winners And Losers Of Monday's Euronext Sessionhttps://t.co/e1lMLKc98D(VIANEWS) - Another dayâ€¦ https://t.co/XeQb1wlthU,neutral,0.07,0.87,0.06,neutral,0.07,0.87,0.06,True,English,"['Euronext Session', 'List', 'Winners', 'Losers', 'Monday', 'VIANEWS', 'XeQb1wlthU', 'Euronext Session', 'List', 'Winners', 'Losers', 'Monday', 'VIANEWS', 'XeQb1wlthU']",2023-04-10,2023-04-10,Unknown
22546,EuroNext,Twitter API,Twitter,@sadvalueinvestr @globalvaluehunt That's euronext,nan,@sadvalueinvestr @globalvaluehunt That's euronext,neutral,0.07,0.92,0.01,neutral,0.07,0.92,0.01,True,English,"['sadvalueinvestr', 'globalvaluehunt', 'sadvalueinvestr', 'globalvaluehunt']",2023-04-10,2023-04-10,Unknown
22547,EuroNext,Twitter API,Twitter,@ReturnsJourney @globalvaluehunt Was hoping for an LSE or Euronext listed biz that has a big Senegalese operation. Iâ€™m sure itâ€™s out there,nan,@ReturnsJourney @globalvaluehunt Was hoping for an LSE or Euronext listed biz that has a big Senegalese operation. Iâ€™m sure itâ€™s out there,neutral,0.23,0.76,0.01,neutral,0.23,0.76,0.01,True,English,"['Euronext listed biz', 'big Senegalese operation', 'ReturnsJourney', 'globalvaluehunt', 'LSE', 'Euronext listed biz', 'big Senegalese operation', 'ReturnsJourney', 'globalvaluehunt', 'LSE']",2023-04-10,2023-04-10,Unknown
22548,EuroNext,Twitter API,Twitter,On this #EasterDay  #SIX and #Euronext are closed.ðŸ‘‰ US stock exchanges remain opened. https://t.co/Dn7m1OPMEM,nan,On this #EasterDay  #SIX and #Euronext are closed.ðŸ‘‰ US stock exchanges remain opened. https://t.co/Dn7m1OPMEM,neutral,0.03,0.96,0.01,neutral,0.03,0.96,0.01,True,English,"['US stock exchanges', 'US stock exchanges']",2023-04-10,2023-04-10,Unknown
22549,EuroNext,Twitter API,Twitter,Euronext $ENX: I've had it in the radar for a long time  and decided to take advantage of a recent correction afterâ€¦ https://t.co/4O7nT26n88,nan,Euronext $ENX: I've had it in the radar for a long time  and decided to take advantage of a recent correction afterâ€¦ https://t.co/4O7nT26n88,neutral,0.28,0.71,0.01,neutral,0.28,0.71,0.01,True,English,"['long time', 'recent correction', 'Euronext', 'radar', 'advantage', 'long time', 'recent correction', 'Euronext', 'radar', 'advantage']",2023-04-09,2023-04-10,Unknown
22550,EuroNext,Twitter API,Twitter,Euronext Migrates Borsa Italiana Equities and ETFs #breakingnews https://t.co/QLLAjnjvCc #finance #financialtrading #news,nan,Euronext Migrates Borsa Italiana Equities and ETFs #breakingnews https://t.co/QLLAjnjvCc #finance #financialtrading #news,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['Borsa Italiana Equities', 'Euronext', 'ETFs', 'breakingnews', 'QLLAjnjvCc', 'finance', 'financialtrading', 'Borsa Italiana Equities', 'Euronext', 'ETFs', 'breakingnews', 'QLLAjnjvCc', 'finance', 'financialtrading']",2023-04-09,2023-04-10,Unknown
